Get started
Author

Hanna Trukhan

38MO Progression-free survival (PFS) in primary advanced or recurrent endometrial cancer (pA/rEC) in the overall and mismatch repair proficient (MMR/MSS) populations and in histological and molecular subgroups: Results from part 2 of the RUBY trial
2024 · M.R. Mirza, S. Ghamande, et al. · ESMO Open · 27
PDF
Dostarlimab plus chemotherapy followed by dostarlimab plus niraparib maintenance therapy among patients with primary advanced or recurrent endometrial cancer in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial
2024 · Mansoor Mirza, Sharad Ghamande, et al. · Gynecologic Oncology · 25
Prognostic factors in patients with uterine sarcoma: the SARCUT study
2023 · Ignacio Zapardiel, Myriam Gracia Segovia, et al. · International Journal of Gynecological Cancer · 24
SUROVA study: global real-world treatment strategies and mortality risk prediction in advanced ovarian cancer
2025 · Luis Chiva, Pilar Ordas, et al. · International Journal of Gynecological Cancer · 17
Impact of Hospital Case Volume on Uterine Sarcoma Prognosis: SARCUT Study Subanalysis
2023 · Mikel Gorostidi, Yusuf Yildirim, et al. · Annals of Surgical Oncology · 3
Twenty years’ experience of primary vaginal cancer treatment at one cancer centre: does residence status matter?
2021 · Olga P Matylevich, Hanna V Trukhan, et al. · ecancermedicalscience · 2
PDF
Prognostic Value of Lymph Node Ratio in Patients with Uterine Carcinosarcoma
2024 · Rasiah Bharathan, Stephan Polterauer, et al. · Journal of Personalized Medicine · 1
PDF
Genetic as a burden or final importance in maintenance therapy of advanced ovarian cancer.
2026 · Hanna Trukhan, Volha Siarheyeva, et al. · International Journal of Gynecological Cancer
Olaparib in the maintenance therapy of advanced ovarian cancer: first experiences in safety and efficacy from belarus
2026 · Hanna Trukhan, Volha Siarheyeva, et al. · International Journal of Gynecological Cancer
How important is the risk-reduced surgery (RRS) for hereditary ovarian cancer in the republic of belarus?
2026 · Hanna Trukhan, Alena Dalamanava, et al. · International Journal of Gynecological Cancer
1102P Contribution of bevacizumab (bev) use to safety outcomes in FIRST/ENGOT-OV44
2025 · A. Redondo, A. Santillan-Gomez, et al. · Annals of Oncology
Recurrent Aggressive Angiomyxoma: A Single-Institution Case Series on Management and Outcomes
2025 · Maksim Isachanka, Sergey Mavrichev, et al. · Research Square
PDF
Fanconi Anemia As A Result Next-Generation Sequencing Of Ovarian Cancer
2025 · Hanna Trukhan, Yuliya Vasilevskaya, et al. · International Journal of Gynecological Cancer
PDF
The Importance Of A Next-Generation Sequencing (NGS) For Hereditary Breast And Ovarian Cancer Syndrome (HBOS): Belarusian Experience
2025 · Hanna Trukhan, Yuliya Vasilevskaya, et al. · International Journal of Gynecological Cancer
PDF
Double Threat: Concurrent BRCA1 And VHL Mutations In A Patient With Ovarian Cancer
2025 · Hanna Trukhan, Yuliya Vasilevskaya, et al. · International Journal of Gynecological Cancer
1257 Risk of developing brain metastasis with BRCA mutation from ovarian cancer: retrospective monocentric study
2024 · Hanna Trukhan, Valeria Skachkova, et al. · International Journal of Gynecological Cancer
1008 Risk-reducing surgery (RRS) in hereditary breast and ovarian cancer syndrome (HBOS): retrospective monocentric study
2024 · Hanna Trukhan, Sergey Mavrichev, et al. · International Journal of Gynecological Cancer
1230 BRCA mutations in ovarian carcinoma, fallopian tube carcinoma and primary peritoneal cancer in Mogilev region (Belarus)
2024 · Hanna Trukhan, Helen Suboch, et al. · International Journal of Gynecological Cancer
#584 Patients with brain metastases from ovarian cancer
2023 · Hanna Trukhan, Valeria Skachkova, et al. · International Journal of Gynecological Cancer
PDF
#580 Treatment options for patients with brain metastases from ovarian cancer: retrospective monocentric study
2023 · Hanna Trukhan, Valeria Skachkova, et al. · International Journal of Gynecological Cancer
PDF
#583 Survival of patients with brain metastases from ovarian cancer: retrospective monocentric study
2023 · Hanna Trukhan, Valeria Skachkova, et al. · International Journal of Gynecological Cancer
PDF
2022-RA-1119-ESGO Burdened family history in patients with ovarian cancer: retrospective monocentric study
2022 · Hanna Trukhan, Yuliya Lufiarova Lufiarova, et al. · International Journal of Gynecological Cancer
PDF
2022-RA-1114-ESGO BRCA I, BRCA II mutation in high grade ovarian cancers, fallopian tube cancer, primary peritoneal carcinoma
2022 · Hanna Trukhan, Valeria Skachkova, et al. · International Journal of Gynecological Cancer
PDF
EPV290/#90 Long-term results of primary vaginal cancer treatment: the Belarus national cancer centre experience
2021 · O. Matylevich, H. Trukhan, et al. · International Journal of Gynecological Cancer
PDF
Analysis of the State of Elaboration of Thepreparing Future Teachers’ Problem for the Provision of Facilitated Pedagogicalsupport for Families in Ukraine
2020 · Hanna Trukhan · Bulletin of Luhansk Taras Shevchenko National University
PDF
Works count: 25
Citation count: 99
H-index: 4
I10-index: 4
Year
Topic
Type